Covered recipient · General Payments record
BARBARA PAULO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2024
$1,545.43
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $933.67 | 49 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $459.86 | 26 |
| Corium, Inc. | $120.82 | 6 |
| Janssen Pharmaceuticals, Inc | $49.43 | 2 |
| Almatica Pharma Inc. | $27.65 | 1 |
| Neurocrine BioSciences, Inc. | $27.15 | 1 |
| Neuronetics, Inc. | $23.82 | 1 |
| ITI, Inc. | $23.42 | 1 |
| Lundbeck LLC | $22.65 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.83 | 1 |
| Alkermes, Inc. | $21.15 | 1 |
| Noven Therapeutics, LLC | $20.71 | 1 |
| Supernus Pharmaceuticals, Inc. | $19.80 | 1 |
| Axsome Therapeutics, Inc. | $18.39 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $17.36 | 1 |
| Neos Therapeutics, LP | $16.35 | 1 |
| Tris Pharma Inc | $15.37 | 1 |
| Vanda Pharmaceuticals Inc. | $14.10 | 1 |
| Tempus AI, Inc | $13.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (49)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.68 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819583 | CMS |
| ABBVIE INC. | $23.04 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819587 | CMS |
| ABBVIE INC. | $8.50 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819592 | CMS |
| ABBVIE INC. | $29.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819597 | CMS |
| ABBVIE INC. | $17.49 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819601 | CMS |
| ABBVIE INC. | $20.91 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819606 | CMS |
| ABBVIE INC. | $26.14 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819610 | CMS |
| ABBVIE INC. | $30.58 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819615 | CMS |
| ABBVIE INC. | $13.29 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819620 | CMS |
| ABBVIE INC. | $24.50 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819624 | CMS |
| ABBVIE INC. | $15.06 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819629 | CMS |
| ABBVIE INC. | $16.90 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819633 | CMS |
| ABBVIE INC. | $7.90 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819638 | CMS |
| ABBVIE INC. | $10.90 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819642 | CMS |
| ABBVIE INC. | $15.35 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819647 | CMS |
| ABBVIE INC. | $10.90 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819651 | CMS |
| ABBVIE INC. | $27.12 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819656 | CMS |
| ABBVIE INC. | $8.73 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819660 | CMS |
| ABBVIE INC. | $8.73 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819665 | CMS |
| ABBVIE INC. | $6.64 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819670 | CMS |
| ABBVIE INC. | $8.58 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819674 | CMS |
| ABBVIE INC. | $30.28 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819679 | CMS |
| ABBVIE INC. | $20.43 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819683 | CMS |
| ABBVIE INC. | $20.05 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819688 | CMS |
| ABBVIE INC. | $8.57 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819693 | CMS |
| ABBVIE INC. | $31.25 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107819697 | CMS |
| Alkermes, Inc. | $21.15 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120571493 | CMS |
| Almatica Pharma LLC | $27.65 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137612031 | CMS |
| Axsome Therapeutics, Inc. | $18.39 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148339933 | CMS |
| Corium, LLC | $6.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100129104 | CMS |
| Corium, LLC | $21.44 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100181868 | CMS |
| Corium, LLC | $33.18 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204482 | CMS |
| Corium, LLC | $25.44 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100192543 | CMS |
| Corium, LLC | $13.77 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100161835 | CMS |
| Corium, LLC | $20.19 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100178288 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $17.36 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146276140 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.42 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143580042 | CMS |
| Janssen Pharmaceuticals, Inc | $28.47 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078132025 | CMS |
| Janssen Pharmaceuticals, Inc | $20.96 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078131999 | CMS |
| Lundbeck LLC | $22.65 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146073782 | CMS |
| Neos Therapeutics, LP | $16.35 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082667927 | CMS |
| Neurocrine Biosciences, Inc. | $27.15 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150947445 | CMS |
| Neuronetics, Inc. | $23.82 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073310164 | CMS |
| Noven Therapeutics, LLC | $20.71 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084828238 | CMS |
| Supernus Pharmaceuticals, Inc. | $19.80 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147811251 | CMS |
| Tempus AI, Inc | $13.81 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150185692 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.83 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151659585 | CMS |
| Tris Pharma Inc | $15.37 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147227175 | CMS |
| Vanda Pharmaceuticals Inc. | $14.10 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133963523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.